Case Control Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Jul 21, 2024; 30(27): 3290-3303
Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3290
Table 4 Changes in fatty-acid content in lean metabolic-associated fatty liver disease patients, n = 6
No.
Name
Lean MAFLD patients
Normal individuals
1Palmitic acid3.41 ± 0.84a1.53 ± 0.85
2Oleic acid2.63 ± 1.45a1.26 ± 0.65
3Linoleic acid2.42 ± 1.18a1.30 ± 0.49
4Arachidonic acid2.45 ± 1.21a1.24 ± 0.56